DOV
55
14
SHW
46
-12
PLD
46
6
PNC
67
6
CPB
44
2
KMI
46
-2
SYK
48
2
WM
68
-2
BDX
33
3
SEE
55
5
DVN
29
2
CTSH
52
2
ZBH
53
2
UAL
51
4
ETN
71
2
MPC
42
6
LUV
57
3
MAT
46
3
EIX
45
2
MRK
48
2
DOV
55
14
SHW
46
-12
PLD
46
6
PNC
67
6
CPB
44
2
KMI
46
-2
SYK
48
2
WM
68
-2
BDX
33
3
SEE
55
5
DVN
29
2
CTSH
52
2
ZBH
53
2
UAL
51
4
ETN
71
2
MPC
42
6
LUV
57
3
MAT
46
3
EIX
45
2
MRK
48
2
Financhill
Back

ProShares UltraShort MSCI Emerging Markets Vs. Akero Therapeutics Industry Stock Comparison

Sell
27

EEV
ProShares UltraShort MSCI Emerging Markets

Last Price:
$14.34
Seasonality Move:
-0.01%
Buy
68

AKRO
Akero Therapeutics

Last Price:
$54.26
Seasonality Move:
26.74%
Sell
27
ProShares UltraShort MSCI Emerging Markets (EEV) is a Sell

Is ProShares UltraShort MSCI Emerging Markets a Buy, Sell or Hold?

  • The current ProShares UltraShort MSCI Emerging Markets [EEV] share price is $13.56. The Score for EEV is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • EEV is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
68
Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $54.28. The Score for AKRO is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

EEV Stock Price Chart

What is ProShares UltraShort MSCI Emerging Markets's stock price today?

  • The ProShares UltraShort MSCI Emerging Markets share price today is $13.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EEV is experiencing slight selling pressure.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $54.28
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.

EEV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.16 Sell
Relative Strength Index (14 RSI): 33.83 Sell
Chaikin Money Flow: -17858 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.76 - 14.46) Sell
Bollinger Bands (100): (14.46 - 17.06) Sell

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.09 Buy
Relative Strength Index (14 RSI): 70.44 Buy
Chaikin Money Flow: -1219058 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.53 - 50.43) Buy
Bollinger Bands (100): (34.89 - 51.35) Buy

EEV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.96 Sell
20-day SMA: 13.98 Sell
50-day SMA: 15.37 Sell
200-day SMA: 16.1 Sell
8-day EMA: 13.86 Sell
20-day EMA: 14.09 Sell
50-day EMA: 13.1 Buy
200-day EMA: 6.43 Buy

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.82 Buy
20-day SMA: 46 Buy
50-day SMA: 42.47 Buy
200-day SMA: 36.08 Buy
8-day EMA: 51.3 Buy
20-day EMA: 47.76 Buy
50-day EMA: 44.57 Buy
200-day EMA: 37.75 Buy

ProShares UltraShort MSCI Emerging Markets Earnings Growth & EEV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.

ProShares UltraShort MSCI Emerging Markets Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):